{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:41:44Z","timestamp":1791884504728,"version":"4.3.4"},"reference-count":165,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.kint.2017.11.007","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T22:07:59Z","timestamp":1517609279000},"page":"545-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":219,"title":["Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving\u00a0Global Outcomes (KDIGO) Controversies\u00a0Conference"],"prefix":"10.1016","volume":"93","author":[{"given":"Charles R.","family":"Swanepoel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed G.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivette D.","family":"D\u2019Agati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes B.","family":"Fogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saraladevi","family":"Naicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Wearne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abu-Alfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwomoa","family":"Adu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Y.","family":"Agodoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Alpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiu A.","family":"Arogundade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ashuntantang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne I.","family":"Bagnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Bhimma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Brocheriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur H.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"de Seigneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric O.","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hamzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Hendry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Imonje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Charles","family":"Jennette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Klotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Klotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon I.","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulane","family":"Mosiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia C.","family":"Nast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikechi G.","family":"Okpechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio E.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Ryom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoma","family":"Ulasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liffert","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.11.007_bib1","unstructured":"UNAIDS. AIDSinfo. Available at: http:\/\/aidsinfo.unaids.org\/. Accessed July 19,\u00a02017."},{"key":"10.1016\/j.kint.2017.11.007_bib2","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1093\/cid\/ciu617","article-title":"Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"59","author":"Lucas","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nrneph.2015.9","article-title":"HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment","volume":"11","author":"Rosenberg","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1681\/ASN.V81138","article-title":"HIV infection and the kidney","volume":"8","author":"D'Agati","year":"1997","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/ki.2014.167","article-title":"Advances in the pathogenesis of HIV-associated kidney diseases","volume":"86","author":"Ross","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib6","first-page":"87","article-title":"HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion","volume":"1","author":"Cohen","year":"1988","journal-title":"Mod Pathol"},{"key":"10.1016\/j.kint.2017.11.007_bib7","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/ki.1989.135","article-title":"Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study","volume":"35","author":"D'Agati","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.ki.5001574","article-title":"Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells","volume":"70","author":"Dijkman","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semnephrol.2008.08.005","article-title":"HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy","volume":"28","author":"Wyatt","year":"2008","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib10","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1093\/ndt\/gfr702","article-title":"The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations","volume":"27","author":"Wearne","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0046-8177(94)90166-X","article-title":"Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study","volume":"25","author":"Nadasdy","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.kint.2017.11.007_bib12","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1681\/ASN.V12122645","article-title":"Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy","volume":"12","author":"Ross","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ki.2008.303","article-title":"HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells","volume":"74","author":"Rosenstiel","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000112851","article-title":"Observations on a cohort of HIV-infected patients undergoing native renal biopsy","volume":"28","author":"Berliner","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib15","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfr676","article-title":"HIV-associated kidney glomerular diseases: changes with time and HAART","volume":"27","author":"Lescure","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ki.2014.44","article-title":"The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy","volume":"86","author":"Mallipattu","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM198909073211001","article-title":"Renal disease in children with the acquired immunodeficiency syndrome","volume":"321","author":"Strauss","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2015.216","article-title":"HIV-associated immune complex kidney disease","volume":"12","author":"Nobakht","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM199209033271006","article-title":"Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection","volume":"327","author":"Kimmel","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/ki.1993.386","article-title":"HIV-associated immune-mediated renal disease","volume":"44","author":"Kimmel","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib21","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1523-1755.2005.00215.x","article-title":"HIV-associated immune complex glomerulonephritis with \u201clupus-like\u201d features: a clinicopathologic study of 14 cases","volume":"67","author":"Haas","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0272-6386(99)70180-0","article-title":"Renal manifestations of concurrent systemic lupus erythematosus and HIV infection","volume":"33","author":"Chang","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib23","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.ki.5000351","article-title":"HIV-related nephropathy: a South African perspective","volume":"69","author":"Gerntholtz","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib24","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1681\/ASN.V1071566","article-title":"Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection","volume":"10","author":"Cheng","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5414\/CN107774","article-title":"The changing pattern of glomerular disease in HIV and hepatitis C co-infected patients in the era of HAART","volume":"79","author":"Mohan","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0272-6386(97)90332-2","article-title":"Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"29","author":"Stokes","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib27","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ki.2010.318","article-title":"Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities","volume":"78","author":"Herlitz","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.ajkd.2007.12.005","article-title":"Kidney biopsy in HIV: beyond HIV-associated nephropathy","volume":"51","author":"Fine","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2215\/CJN.08211109","article-title":"Characteristics of patients with HIV and biopsy-proven acute interstitial nephritis","volume":"5","author":"Parkhie","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2215\/CJN.10051012","article-title":"Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study","volume":"8","author":"Zaidan","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.berh.2015.04.019","article-title":"Evolving spectrum of HIV-associated rheumatic syndromes","volume":"29","author":"Fox","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.kint.2017.11.007_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2010.12.010","article-title":"Diffuse infiltrative lymphocytosis syndrome presenting as reversible acute kidney injury associated with Gram-negative bacterial infection in patients with newly diagnosed HIV infection","volume":"57","author":"Yoo","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.ki.5002207","article-title":"Nephropathy associated with the diffuse infiltrative lymphocytosis syndrome","volume":"72","author":"Zafrani","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib34","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1093\/ndt\/gfr197","article-title":"Mycobacterial-immune reconstitution inflammatory syndrome: a cause of acute interstitial nephritis during HIV infection","volume":"26","author":"Martin-Blondel","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ajh.2830400206","article-title":"Thrombotic thrombocytopenic purpura in patients with human immunodeficiency virus infection: a report of three cases and review of the literature","volume":"40","author":"Rarick","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.kint.2017.11.007_bib36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/clinids\/17.3.360","article-title":"Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: demonstration of p24 antigen in endothelial cells","volume":"17","author":"del Arco","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaf6925","article-title":"In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide","volume":"1","author":"Remark","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.kint.2017.11.007_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.kint.2017.11.007_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa0698","article-title":"Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome","volume":"348","author":"Xu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.kint.2017.11.007_bib40","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1046\/j.1523-1755.63.s83.10.x","article-title":"HIV-associated nephropathy in African Americans","author":"Kopp","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2017.11.007_bib41","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2017.11.007_bib42","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ng.232","article-title":"MYH9 is associated with nondiabetic end-stage renal disease in African Americans","volume":"40","author":"Kao","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2017.11.007_bib43","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/hmg\/ddq040","article-title":"African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans","volume":"19","author":"Behar","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.kint.2017.11.007_bib44","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/hmg\/ddq039","article-title":"Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15","volume":"19","author":"Nelson","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.kint.2017.11.007_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.kint.2017.11.007_bib46","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.kint.2017.11.007_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.kint.2017.11.007_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.25461","article-title":"APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis","volume":"6","author":"Cooper","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.kint.2017.11.007_bib49","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.ackd.2014.06.005","article-title":"APOL1 kidney risk alleles: population genetics and disease associations","volume":"21","author":"Limou","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib51","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-Associated nephropathy in Black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib52","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000332378","article-title":"Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population","volume":"34","author":"Behar","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib53","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.semnephrol.2015.04.008","article-title":"APOL1 Kidney Disease risk variants: an evolving landscape","volume":"35","author":"Dummer","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ki.2012.111","article-title":"HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics","volume":"82","author":"Atta","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajhg.2013.05.014","article-title":"Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations","volume":"93","author":"Ko","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.kint.2017.11.007_bib56","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2215\/CJN.07490715","article-title":"Association of APOL1 genotype with renal histology among Black HIV-positive patients undergoing kidney biopsy","volume":"11","author":"Atta","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1681\/ASN.2011060562","article-title":"APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease","volume":"23","author":"Fine","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib58","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1681\/ASN.2013111242","article-title":"Clinical features and histology of apolipoprotein L1-associated nephropathy in the FSGS clinical trial","volume":"26","author":"Kopp","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib59","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/cid\/ciu765","article-title":"The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status","volume":"60","author":"Estrella","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib60","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ki.2013.203","article-title":"Host APOL1 genotype is independently associated with proteinuria in HIV infection","volume":"84","author":"Estrella","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib61","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2017.11.007_bib62","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib63","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.2016050550","article-title":"APOL1-G1 in nephrocytes induces hypertrophy and accelerates cell death","volume":"28","author":"Fu","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib64","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1681\/ASN.2016050546","article-title":"APOL1-mediated cell injury involves disruption of conserved trafficking processes","volume":"28","author":"Kruzel-Davila","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib65","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2016050567","article-title":"APOL1 renal-risk variants induce mitochondrial dysfunction","volume":"28","author":"Ma","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib66","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2017.11.007_bib67","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1681\/ASN.2015111220","article-title":"APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease","volume":"27","author":"Bruggeman","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib68","doi-asserted-by":"crossref","first-page":"21540","DOI":"10.1074\/jbc.M800214200","article-title":"Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death","volume":"283","author":"Wan","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2017.11.007_bib69","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"Lan","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.11.007_bib70","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/ndt\/gfl337","article-title":"Antiretroviral therapy in the treatment of HIV-associated nephropathy","volume":"21","author":"Atta","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib71","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/ndt\/gfv436","article-title":"Clinical characteristics and outcomes of HIV-associated immune complex kidney disease","volume":"31","author":"Booth","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib72","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.2215\/CJN.10991012","article-title":"Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy","volume":"8","author":"Foy","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib73","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/QAD.0b013e32833c85d6","article-title":"Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure","volume":"24","author":"Ibrahim","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001809","article-title":"Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study","volume":"12","author":"Mocroft","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.kint.2017.11.007_bib75","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/QAD.0000000000000258","article-title":"A\u00a0chronic kidney disease risk score to determine tenofovir safety in a prospective cohort of HIV-positive male veterans","volume":"28","author":"Scherzer","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib76","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1468-1293.2009.00716.x","article-title":"Tenofovir-associated renal and bone toxicity","volume":"10","author":"Woodward","year":"2009","journal-title":"HIV Med"},{"key":"10.1016\/j.kint.2017.11.007_bib77","first-page":"492","article-title":"Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate","volume":"74","author":"Hamzah","year":"2017","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.kint.2017.11.007_bib78","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/S2352-3018(15)00211-8","article-title":"Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study","volume":"3","author":"Mocroft","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.kint.2017.11.007_bib79","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of tenofovir exposure with kidney disease risk in HIV infection","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib80","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/infdis\/jiu107","article-title":"Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure","volume":"210","author":"Jose","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib81","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/QAI.0000000000001186","article-title":"Brief report: switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-Infected adults with renal impairment: 96-week results from a single-arm, multicenter, open-label phase 3 study","volume":"74","author":"Post","year":"2017","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.kint.2017.11.007_bib82","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/QAD.0000000000001464","article-title":"Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals","volume":"31","author":"Ryom","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib83","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ckj\/sfv041","article-title":"Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series","volume":"8","author":"Waheed","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2017.11.007_bib84","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/QAD.0000000000000736","article-title":"Renal tubular disease in the era of combination antiretroviral therapy","volume":"29","author":"Hamzah","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib85","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/QAD.0000000000000563","article-title":"Acute interstitial nephritis caused by lopinavir\/ritonavir in a surgeon receiving antiretroviral postexposure prophylaxis","volume":"29","author":"Chughlay","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib86","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00002030-200403050-00022","article-title":"Lopinavir-ritonavir (Kaletra) and lithiasis: seven cases","volume":"18","author":"Doco-Lecompte","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib87","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/cid\/cis621","article-title":"High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy","volume":"55","author":"Hamada","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib88","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00428-007-0418-3","article-title":"Acute interstitial nephritis of HIV-positive patients under atazanavir and tenofovir therapy in a retrospective analysis of kidney biopsies","volume":"450","author":"Schmid","year":"2007","journal-title":"Virchows Arch"},{"issue":"Suppl 1","key":"10.1016\/j.kint.2017.11.007_bib89","first-page":"60","article-title":"Ritonavir-induced acute kidney injury: kidney biopsy findings and review of literature","volume":"75","author":"Shafi","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib90","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/QAD.0000000000001353","article-title":"Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir","volume":"31","author":"Jose","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib91","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1473-3099(14)70736-4","volume":"14","author":"Cahn","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib92","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1473-3099(15)00097-3","article-title":"Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial","volume":"15","author":"Perez-Molina","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib93","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/S0140-6736(14)61170-3","article-title":"Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001\/ANRS143 randomised non-inferiority trial","volume":"384","author":"Raffi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.11.007_bib94","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/cid\/ciu919","article-title":"End-stage renal disease among HIV-infected adults in North America","volume":"60","author":"Abraham","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib95","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.11.007_bib96","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/cid\/ciw804","article-title":"First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013","volume":"64","author":"Wong","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib97","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/infdis\/jit373","article-title":"Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals","volume":"208","author":"Lucas","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040245","article-title":"Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults","volume":"7","author":"Mocroft","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2017.11.007_bib99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1053\/j.ajkd.2016.01.017","article-title":"CKD and infectious diseases in Asia Pacific: challenges and opportunities","volume":"68","author":"Jha","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hcu220","article-title":"The risk of chronic kidney disease in tuberculosis: a population-based cohort study","volume":"108","author":"Shen","year":"2015","journal-title":"QJM"},{"key":"10.1016\/j.kint.2017.11.007_bib101","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5414\/CNP71310","article-title":"Crescentic glomerulonephritis associated with miliary tuberculosis","volume":"71","author":"Wen","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib102","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ki.2010.171","article-title":"Long-term clinical consequences of acute kidney injury in the HIV-infected","volume":"78","author":"Choi","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib103","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2017.11.007_bib104","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.ajkd.2010.05.019","article-title":"Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons","volume":"56","author":"Choi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib105","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib106","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/QAI.0b013e31826a6c4f","article-title":"Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals","volume":"61","author":"Inker","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.kint.2017.11.007_bib107","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/hiv.12087","article-title":"Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals","volume":"15","author":"Lucas","year":"2014","journal-title":"HIV Med"},{"key":"10.1016\/j.kint.2017.11.007_bib108","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0004563215579695","article-title":"Cystatin C- and creatinine-based equations in the assessment of renal function in HIV-positive patients prior to commencing highly active antiretroviral therapy","volume":"53","author":"Seape","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.kint.2017.11.007_bib109","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QAD.0000000000000103","article-title":"Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity","volume":"28","author":"Yombi","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib110","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib111","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.mcna.2004.11.009","article-title":"Measurement of kidney function","volume":"89","author":"Stevens","year":"2005","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.kint.2017.11.007_bib112","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","article-title":"Factors other than glomerular filtration rate affect serum cystatin C levels","volume":"75","author":"Stevens","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib113","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/hiv.12249","article-title":"Monitoring of kidney function in HIV-positive patients","volume":"16","author":"Yombi","year":"2015","journal-title":"HIV Med"},{"key":"10.1016\/j.kint.2017.11.007_bib114","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007183.pub2","article-title":"Interventions for HIV-associated nephropathy","author":"Yahaya","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2017.11.007_bib115","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations. Geneva, Switzerland;\u00a02014."},{"key":"10.1016\/j.kint.2017.11.007_bib116","first-page":"337","article-title":"KDIGO Clinical Practice Guidelines for the Management of Blood Pressure in Chronic Kidney Disease","volume":"2","year":"2012","journal-title":"Kidney Intl Suppl"},{"key":"10.1016\/j.kint.2017.11.007_bib117","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0Randomized Trial of Intensive versus Standard Blood-Pressure Control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib118","unstructured":"World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva, Switzerland;\u00a02015."},{"key":"10.1016\/j.kint.2017.11.007_bib119","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw566","article-title":"Executive Summary: Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib120","first-page":"32","article-title":"An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO Guidelines","volume":"32","author":"Pol","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib121","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.11.007_bib122","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1097\/01.ASN.0000019773.43765.BF","article-title":"Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States","volume":"13","author":"Ahuja","year":"2002","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib123","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0272-6386(03)00204-X","article-title":"Is dialysis modality a factor in survival of patients with ESRD and HIV-associated nephropathy?","volume":"41","author":"Ahuja","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.007_bib124","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11255-006-0080-8","article-title":"Survival and morbidity of HIV patients on hemodialysis and peritoneal dialysis: one center's experience and review of the literature","volume":"38","author":"Soleymanian","year":"2006","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/ndt\/gfl629","article-title":"Arteriovenous access outcomes in haemodialysis patients with HIV infection","volume":"22","author":"Mitchell","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib126","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1099-1654(199904\/06)9:2<101::AID-RMV234>3.0.CO;2-U","article-title":"Blood-borne virus infections in dialysis units\u2013a review","volume":"9","author":"Wreghitt","year":"1999","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.kint.2017.11.007_bib127","first-page":"376","article-title":"Current trends recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III\/lymphadenopathy-associated virus","volume":"35","author":"Centers for Disease Control and Prevention","year":"1986","journal-title":"MMWR"},{"key":"10.1016\/j.kint.2017.11.007_bib128","unstructured":"Centers for Disease Control and Prevention. Preventing infections in dialysis setting guideline. Available at: https:\/\/www.cdc.gov\/infectioncontrol\/guidelines\/dialysis\/index.html. Accessed July 19,\u00a02017."},{"key":"10.1016\/j.kint.2017.11.007_bib129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12882-017-0466-0","article-title":"Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study","volume":"18","author":"Ndlovu","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib130","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/ki.1996.482","article-title":"HIV-1 survival kinetics in peritoneal dialysis effluent","volume":"50","author":"Farzadegan","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.007_bib131","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ndt\/gfx001","article-title":"Detection of human immunodeficiency virus-1 ribonucleic acid in the peritoneal effluent of renal failure patients on highly active antiretroviral therapy","volume":"32","author":"Ndlovu","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib132","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa1001197","article-title":"Outcomes of kidney transplantation in HIV-infected recipients","volume":"363","author":"Stock","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib133","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/SLA.0000000000001761","article-title":"Survival benefit of kidney transplantation in HIV-infected patients","volume":"265","author":"Locke","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.kint.2017.11.007_bib134","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0956462413493266","article-title":"Kidney transplantation in HIV-positive adults: the UK experience","volume":"25","author":"Gathogo","year":"2014","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib135","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/QAD.0000000000001457","article-title":"Kidney transplant outcomes in HIV serodiscordant recipient pairs","volume":"31","author":"Gathogo","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib136","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2215\/CJN.07460716","article-title":"Access to kidney transplantation among HIV-infected waitlist candidates","volume":"12","author":"Locke","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib137","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1408896","article-title":"HIV-positive-to-HIV-positive kidney transplantation\u2013results at 3 to 5 years","volume":"372","author":"Muller","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129702","article-title":"Outcomes of renal transplantation in HIV-1 associated nephropathy","volume":"10","author":"Waheed","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2017.11.007_bib139","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/QAD.0000000000001413","article-title":"Alemtuzumab induction therapy in HIV-positive renal transplant recipients","volume":"31","author":"McLean","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.kint.2017.11.007_bib140","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/TP.0000000000000879","article-title":"Impact of tacrolimus compared with cyclosporin on the incidence of acute allograft rejection in human immunodeficiency virus-positive kidney transplant recipients","volume":"100","author":"Gathogo","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2017.11.007_bib141","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.11.007_bib142","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.2215\/CJN.04410512","article-title":"Common infections in kidney transplant recipients","volume":"7","author":"Karuthu","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib143","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"109","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2017.11.007_bib144","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.11.007_bib145","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1111\/ajt.14419","article-title":"Impact of protease inhibitor based anti-retroviral therapy on outcomes for HIV+ kidney transplant recipients","volume":"17","author":"Sawinski","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib146","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2013050564","article-title":"The kidney as a reservoir for HIV-1 after renal transplantation","volume":"25","author":"Canaud","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib147","unstructured":"APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01), RFA-DK-16\u2013025. In: Department of Health and Human Services N, ed. Available at: https:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-DK-16-025.html. Accessed June 19,\u00a02017."},{"key":"10.1016\/j.kint.2017.11.007_bib148","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1056\/NEJMoa1408896","article-title":"HIV-positive-to-HIV-positive kidney transplantation","volume":"372","author":"Muller","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib149","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMc0900837","article-title":"Renal transplantation between HIV-positive donors and recipients","volume":"362","author":"Muller","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib150","first-page":"26464","article-title":"Organ procurement and transplantation: implementation of the HIV Organ Policy Equity Act. Final rule","volume":"80","year":"2015","journal-title":"Fed Regist"},{"key":"10.1016\/j.kint.2017.11.007_bib151","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/SLA.0000000000001352","article-title":"From bench to bill: how a transplant nuance became 1 of only 57 laws passed in 2013","volume":"263","author":"Boyarsky","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.kint.2017.11.007_bib152","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1681\/ASN.2011040434","article-title":"APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy","volume":"22","author":"Papeta","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib153","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/QAI.0000000000001010","article-title":"Brief report: APOL1 renal risk variants are associated with chronic kidney disease in children and youth with perinatal HIV infection","volume":"73","author":"Purswani","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.kint.2017.11.007_bib154","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials","volume":"385","author":"Sax","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.11.007_bib155","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncpneph0953","article-title":"KDIGO clinical practice guidelines on hepatitis C in chronic kidney disease acknowledged by ISN","volume":"4","author":"Abboud","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.kint.2017.11.007_bib156","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/jvh.12681","article-title":"Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories","volume":"24","author":"Mendizabal","year":"2017","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.kint.2017.11.007_bib157","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1053\/j.gastro.2016.02.078","article-title":"Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease","volume":"150","author":"Pockros","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.11.007_bib158","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study","volume":"386","author":"Roth","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.11.007_bib159","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jhep.2015.06.004","article-title":"Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease","volume":"63","author":"Bhamidimarri","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.11.007_bib160","first-page":"2065","article-title":"Sofosbuvir-based antiviral therapy in hepatitis C virus patients with severe renal failure","volume":"32","author":"Dumortier","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.11.007_bib161","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/liv.13102","article-title":"Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function","volume":"36","author":"Saxena","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.kint.2017.11.007_bib162","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc09-0177","article-title":"A1C underestimates glycemia in HIV infection","volume":"32","author":"Kim","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2017.11.007_bib163","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1093\/jac\/dku295","article-title":"Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters","volume":"69","author":"Slama","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.kint.2017.11.007_bib164","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1704053","article-title":"Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment","volume":"377","author":"Gane","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2017.11.007_bib165","unstructured":"AASLD\/IDSA. HCV guidance: recommendations for testing, managing, and treating hepatitis C. Patients with renal impairment. Available at: https:\/\/www.hcvguidelines.org\/unique-populations\/renal-impairment. Accessed December 20, 2017."}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817308232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817308232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T10:02:16Z","timestamp":1751277736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253817308232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":165,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0085253817308232"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.11.007","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving\u00a0Global Outcomes (KDIGO) Controversies\u00a0Conference","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}